| 1. |
Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology, 2015, 85(2): 177-189. DOI: 10.1212/WNL.0000000000001729.
|
| 2. |
Patrick P, Monika B, Romana H, et al. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases[J]. Front Immunol, 2017, 8: 529. DOI: 10.3389/fimmu.2017.00529.
|
| 3. |
Thulasirajah S, Pohl D, Davilaacosta J, et al. Myelin oligodendrocyte glycoprotein- associated pediatric central nervous system demyelination: clinical course, neuroimaging findings, and response to therapy[J]. Neuropediatrics, 2016, 47(4): 245-252. DOI: 10.1055/s-0036-1583184.
|
| 4. |
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis[J]. Lancet, 2004, 364(9451): 2106-2112. DOI: 10.1016/S0140-6736(04)17551-X.
|
| 5. |
Mariotto S, Ferrari S, Monaco S, et al. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study[J]. J Neurol, 2017, 264(12): 2420-2430. DOI: 10.1007/s00415-017-8635-4.
|
| 6. |
Kezuka T, Ishikawa H. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis[J]. Jpn J Ophthalmol, 2018, 62(2): 101-108. DOI: 10.1007/s10384-018-0561-1.
|
| 7. |
Hennes EM, Baumann M, Schanda K, et al. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome[J]. Neurology, 2017, 89(9): 900-908. DOI: 10.1212/WNL.0000000000004312.
|
| 8. |
Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease[J]. J Neurol, 2019, 266(5): 1280-1286. DOI: 10.1007/s00415-018-9122-2.
|
| 9. |
徐敏, 郭虎, 何燕, 等. 儿童髓鞘少突胶质细胞糖蛋白抗体脑脊髓炎13例临床与影像学特征[J]. 中华实用儿科临床杂志, 2019, 34(13): 997-1001. DOI: 10.3760/cma.j.issn.2095-428X.2019.13.008.Xu M, Guo H, He Y, et al. Clinical and imaging features of 13 children with myelin oligodendrocyte glycoprotein antibody encephalomyelitis[J]. Journal of Applied Clinical Pediatrics, 2019, 34(13): 997-1001. DOI: 10.3760/cma.j.issn.2095-428X.2019.13.008.
|
| 10. |
张敏, 李文辉, 杨皓玮, 等. 髓鞘少突胶质细胞糖蛋白抗体阳性的儿童中枢神经系统脱髓鞘病变首次发作的临床和影像学特点[J]. 中华神经科杂志, 2018, 51(2): 97-104. DOI: 10.3760/cma.j.issn.1006-7876.2018.02.004.Zhang M, Li WH, Yang HW, et al. The clinical and radiological features of children with first attack of inflammatory demyelinating central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein[J]. Chin J Neurol, 2018, 51(2): 97-104. DOI: 10.3760/cma.j.issn.1006-7876.2018.02.004.
|
| 11. |
Hyun JW, Kwon YN, Lee HL, et al. Recurrence of clinical events at the same anatomical location in patients with MOG antibody-associated disease[J/OL].Mult Scler, 2020, 2020:E1[2020-03-31].http://journals.sagepub.com/doi/full/10.1177/1352458520913970?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed. DOI:10.1177/1352458520913970. [published online ahead of print].
|
